NewcelX FY26 H1 net loss attributable to common shareholders narrows 50% to USD 5.63 million
NewcelX posted a net loss attributable to common shareholders of USD 5.63 million for the six months ended June 30, 2026. Operating loss widened 107.86% to USD 2.83 million, while total loss narrowed 74.23% to USD 2.9 million. Research and development costs more than doubled to USD 1.17 million, and general and adminis